BRIACELL THERAP (BCTX) Competitors $2.91 -0.02 (-0.65%) Closing price 07/3/2025 03:08 PM EasternExtended Trading$2.92 +0.00 (+0.14%) As of 07/3/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BCTX vs. CLYM, CABA, MCRB, TCRX, VNRX, SRZN, EPIX, PLRX, MGNX, and ZURAShould you be buying BRIACELL THERAP stock or one of its competitors? The main competitors of BRIACELL THERAP include Climb Bio (CLYM), Cabaletta Bio (CABA), Seres Therapeutics (MCRB), TScan Therapeutics (TCRX), VolitionRx (VNRX), Surrozen (SRZN), ESSA Pharma (EPIX), Pliant Therapeutics (PLRX), MacroGenics (MGNX), and Zura Bio (ZURA). These companies are all part of the "pharmaceutical products" industry. BRIACELL THERAP vs. Its Competitors Climb Bio Cabaletta Bio Seres Therapeutics TScan Therapeutics VolitionRx Surrozen ESSA Pharma Pliant Therapeutics MacroGenics Zura Bio BRIACELL THERAP (NASDAQ:BCTX) and Climb Bio (NASDAQ:CLYM) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability. Which has more volatility & risk, BCTX or CLYM? BRIACELL THERAP has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Climb Bio has a beta of -0.13, suggesting that its share price is 113% less volatile than the S&P 500. Does the media prefer BCTX or CLYM? In the previous week, BRIACELL THERAP had 1 more articles in the media than Climb Bio. MarketBeat recorded 2 mentions for BRIACELL THERAP and 1 mentions for Climb Bio. BRIACELL THERAP's average media sentiment score of 0.00 equaled Climb Bio'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BRIACELL THERAP 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Climb Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is BCTX or CLYM more profitable? Climb Bio's return on equity of -43.95% beat BRIACELL THERAP's return on equity.Company Net Margins Return on Equity Return on Assets BRIACELL THERAPN/A -479.97% -182.26% Climb Bio N/A -43.95%-42.94% Do insiders & institutionals believe in BCTX or CLYM? 15.4% of BRIACELL THERAP shares are held by institutional investors. Comparatively, 69.8% of Climb Bio shares are held by institutional investors. 5.7% of BRIACELL THERAP shares are held by insiders. Comparatively, 0.8% of Climb Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, BCTX or CLYM? Climb Bio is trading at a lower price-to-earnings ratio than BRIACELL THERAP, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBRIACELL THERAPN/AN/A-$4.79M-$8.32-0.35Climb BioN/AN/A-$73.90M-$2.38-0.54 Do analysts prefer BCTX or CLYM? BRIACELL THERAP presently has a consensus price target of $32.00, indicating a potential upside of 999.28%. Climb Bio has a consensus price target of $9.00, indicating a potential upside of 603.13%. Given BRIACELL THERAP's higher probable upside, analysts clearly believe BRIACELL THERAP is more favorable than Climb Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BRIACELL THERAP 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Climb Bio 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 SummaryClimb Bio beats BRIACELL THERAP on 7 of the 12 factors compared between the two stocks. Get BRIACELL THERAP News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BCTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTX vs. The Competition Export to ExcelMetricBRIACELL THERAPMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.72M$2.88B$5.50B$9.01BDividend YieldN/A2.43%5.38%4.04%P/E RatioN/A21.5627.6020.30Price / SalesN/A172.97368.81103.83Price / CashN/A41.9536.6357.47Price / Book1.657.518.055.68Net Income-$4.79M-$55.05M$3.18B$249.13M7 Day Performance-1.66%4.61%2.82%3.30%1 Month Performance-11.52%4.89%3.70%5.20%1 Year Performance-80.59%5.84%35.41%21.38% BRIACELL THERAP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXBRIACELL THERAP2.5627 of 5 stars$2.91-0.6%$32.00+999.3%-80.6%$19.72MN/A0.008CLYMClimb Bio2.6651 of 5 stars$1.24+5.1%$9.00+625.8%N/A$79.74MN/A-0.529Positive NewsCABACabaletta Bio1.7348 of 5 stars$1.52-3.2%$14.43+849.2%-78.7%$79.67MN/A-0.6050MCRBSeres Therapeutics3.076 of 5 stars$11.11+22.1%$73.67+563.1%-19.1%$79.46M$126.32M-2.42330High Trading VolumeTCRXTScan Therapeutics2.0041 of 5 stars$1.45+3.6%$7.80+437.9%-74.2%$79.23M$2.82M-1.33100Positive NewsVNRXVolitionRx1.7115 of 5 stars$0.76-9.3%$3.50+360.5%+22.5%$78.30M$1.31M-2.1180SRZNSurrozen2.4077 of 5 stars$8.94-0.9%$38.50+330.6%-19.1%$77.24M$10.65M-0.3680Gap DownHigh Trading VolumeEPIXESSA Pharma1.3502 of 5 stars$1.70-1.7%$2.00+17.6%-64.1%$76.79MN/A-2.7050News CoveragePositive NewsPLRXPliant Therapeutics4.0068 of 5 stars$1.16-7.2%$13.31+1,047.6%-88.2%$76.73M$1.58M-0.3290High Trading VolumeMGNXMacroGenics4.1189 of 5 stars$1.21+1.7%$5.71+372.3%-65.7%$75.08M$149.96M-1.36430ZURAZura Bio3.3346 of 5 stars$1.05flat$14.33+1,265.1%-67.6%$71.79MN/A-1.503Positive NewsGap Up Related Companies and Tools Related Companies CLYM Alternatives CABA Alternatives MCRB Alternatives TCRX Alternatives VNRX Alternatives SRZN Alternatives EPIX Alternatives PLRX Alternatives MGNX Alternatives ZURA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BCTX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BRIACELL THERAP Please log in to your account or sign up in order to add this asset to your watchlist. Share BRIACELL THERAP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
